GSGuofang Shen

Guofang Shen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guofang Shen has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Yi Wang

    Pharmaceutical Informatics Institute, School of Pharmacy, Zhejiang University, Hangzhou 310058, China

    3 shared publications
  • Yu Tang

    Pharmaceutical Informatics Institute, School of Pharmacy, Zhejiang University, Hangzhou 310058, China

    2 shared publications
  • Cheng Zheng

    Pharmaceutical Informatics Institute, School of Pharmacy, Zhejiang University, Hangzhou 310058, China

    1 shared publication
  • Dan Li

    Pharmaceutical Informatics Institute, School of Pharmacy, Zhejiang University, Hangzhou 310058, China

    1 shared publication
  • Dongfeng Yang

    1 shared publication
  • Funing Huang

    Department of Cardiology, The First Affiliated Hospital of Ningbo University, Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo 315000, China

    1 shared publication

Latest Publications

  • Open Access

    Anti-Hypoxic Phytochemicals in Gao-Shan-Hong-Jing-Tian Oral Liquid: LC-MS Profiling, Network Pharmacology, and Carbonic Anhydrase Inhibition

    by Cheng Zheng, Rui Zhu, Shuyang Hua, Guo-Fang Shen, Shujing Zhang, Yu Tang, Yi Wang

    Gao-shan-hong-jing-tian (GSHJT) Oral Liquid is a phytochemical-rich preparation derived from Rhodiola, yet its anti-hypoxic active constituents and molecular mechanisms remain poorly understood. This study aimed to identify the key anti-hypoxic phytochemicals in GSHJT Oral Liquid and clarify their mechanisms of action to support its potential use in managing acute mountain sickness (AMS). We first established and validated an HPLC method for quality control, then comprehensively profiled the chemical composition using LC-MS. Network pharmacology and molecular docking were applied to predict the core anti-hypoxic components, candidate targets and signaling pathways. The primary bioactivity was further verified through an in vitro carbonic anhydrase (CA) inhibition assay. A total of 71 constituents were identified, with kaempferol and ellagic acid emerging as the primary anti-hypoxic phytochemicals. These compounds target seven core proteins (SRC, PIK3R1, ESR1, EGFR, PTK2, IGF1R, and LYN) to regulate vascular tone, inflammation, oxidative stress, blood–brain barrier integrity, and cell survival under hypoxic conditions. By modulating pathways such as HIF-1α, PI3K/AKT, FAK/PTK2, SRC, and IGF1R, these phytochemicals ultimately influence the onset and alleviation of AMS. Enzyme inhibition assays demonstrated that kaempferol and ellagic acid inhibited CA with IC50 values of 34.05 μM and 119.1 μM, respectively. Molecular docking further revealed that both compounds suppressed CA activity through a combination of hydrogen bonding and hydrophobic interactions, consistent with a zinc-bound water-anchoring mechanism. This study elucidates the phytochemical basis and molecular mechanism responsible for the anti-hypoxic effects of GSHJT Oral Liquid, providing scientific support for its potential application as a natural, plant-derived intervention for preventing and alleviating acute mountain sickness, providing scientific support for its potential application and offering a reproducible paradigm for the rational development of other Rhodiola-based phytomedicines, though further in vivo validation is required to confirm the anti-hypoxic efficacy.


  • Open Access

    Quantitative 1H NMR in Pharmaceutical and Biomedical Analyses: Methodologies and Applications

    by Shangxiao An, Weiyi Zheng, Qi Tang, Guofang Shen, Yi Wang, Hua Hua, Junning Zhao, Yu Tang

    Quantitative 1H NMR (qNMR) is a versatile analytical tool that provides simultaneous structural and quantitative information without the need for analyte-specific standards. This review summarizes its key methodological fundamentals and broad applications in both pharmaceutical and biomedical analysis. In drug analysis, qNMR enables content determination and purity assessment of small molecules, polysaccharides and glycoconjugates, synthetic polymers, and complex herbal medicines. In biomedical analysis, it serves as a powerful platform for metabolomics profiling, real-time monitoring of cellular processes, and absolute quantification of metabolites in biofluids and tissues. Recent and emerging technological advancements, including hyperpolarization, quantum mechanical spectral analysis, artificial intelligence, and deep learning, hold great promise for further enhancing sensitivity, resolving power, and automation. With ongoing integration into pharmacopoeial standards and regulatory frameworks, qNMR is poised to expand its role in both routine quality control and cutting-edge biomedical research.


  • Open Access

    Muscone Promotes PINK1/Parkin-Associated Mitophagy to Suppress NLRP3 Inflammasome Activation: Implications for Endotoxemia Therapy

    by Ziwei Yan, Minrui Li, Dan Li, Wentian Hua, Haoxue Cao, Yufei Li, Li Che, Xiyi Chen, Zhicheng Lai, Yi Wang, et al.

    Background: The NLRP3 inflammasome drives pathological inflammation in various diseases. PINK1/Parkin-associated mitophagy serves as a critical negative regulator of NLRP3 activation, yet pharmacological enhancers remain scarce. Muscone, a natural macrocyclic ketone with blood–brain barrier permeability, exhibits potent anti-inflammatory properties; however, its mechanistic role within the NLRP3-mitophagy axis remains undefined. Methods: LPS/ATP-stimulated macrophages were employed to assess stage-specific effects of muscone on NLRP3 priming (NF-κB signaling, NLRP3, and pro-IL-1β expression) and activation (ASC oligomerization, ASC–pro-caspase 1 complex formation, and IL-1β secretion). RNA sequencing and bioinformatic analysis were performed for pathway enrichment. Mitophagy was characterized by MitoSOX Red staining for mt-ROS detection, electron microscopy, Western blotting of LC3B-II in isolated mitochondria and PINK1 and Parkin in whole-cell lysates, and live-cell mitochondria–lysosome tracking. In vivo protective efficacy was assessed in an LPS-induced endotoxemia mouse model. Results: Muscone dose-dependently suppressed both the priming and activation stages of the NLRP3 inflammasome, maximally reducing IL-1β secretion by ~60% at 50 μM. Mechanistically, muscone amplified PINK1/Parkin-associated mitophagy, scavenging excessive mt-ROS and attenuating NLRP3 activation. These effects were corroborated by RNA-seq and comprehensive functional assays. In vivo, muscone (30 mg/kg) significantly improved survival (3/8 mice alive at 98 h when all LPS controls had died; 2/8 survived to the 132-h endpoint), with concomitant enhancement of mitophagy markers in peritoneal macrophages. Conclusions: Muscone functions as a PINK1/Parkin-associated mitophagy enhancer that maintains mitochondrial quality control during NLRP3-driven inflammatory responses. Its unique macrocyclic structure and blood–brain barrier permeability provide a promising scaffold for developing therapeutics against inflammatory disorders associated with NLRP3 inflammasome activation.

  • Open Access

    SmWRKY33 coordinates tanshinone biosynthesis through concurrent activation of precursor supply and metabolic branch points in Salvia miltiorrhiza

    by Wei Li, Liang Liang, Xue Yan, Guofang Shen, Ziang Yuan, Lu Yuan, Yihong Li, Rui Zhang, Yuwen Liu, Zongqi Yang, et al.


  • Chemical insights into marine lipid oxidation and its dual role in atherosclerosis: implications for food processing and functional food development

    by Jing Xue, Ziyang Hu, Hongjie Chen, Jiaqi Wang, Xiaoping Yang, Funing Huang, Shiqi Wang, Hailong Xiao, Jianjun Jiang, Xinyuan Wang, et al.

  • Open Access

    Optimizing the Salt-Processing Parameters of Achyranthes bidentata and Their Correlation with Anti-Osteoarthritis Effect

    by Jieqiang Zhu, Lisha Shen, Guofang Shen, Yi Tao

    Achyranthes bidentata is always salt-processed before being prescribed for treating osteoarthritis. Yet the salt-processing parameters have not been optimized, and the specific bioactive constituents responsible for the osteoarthritis effect of salt-processed A. bidentata have not been fully elucidated. In this study, a Box–Behnken experimental design was chosen for the optimization of the salt-processing parameters of A. bidentata, including stir-frying time, concentration of brine, and soak time. Meanwhile, HPLC–Q-TOF-MS was utilized to analyze the chemical profiles of various batches of raw and salt-processed A. bidentata. The anti-inflammatory potential of nine batches of both raw and salt-processed A. bidentata was assessed via a cyclooxygenase-2 (COX-2) inhibitory assay. A gray correlation analysis was conducted to correlate the peak areas of the compounds in raw and salt-processed A. bidentata with their COX-2 inhibitory effects. Finally, the optimal salt-processing conditions are as follows: soak time: 29 min; concentration of brine: 1.8%; stir-frying time: 4.4 min. Twenty-nine compounds were identified. Eight compounds were found to have a strong positive correlation with anti-inflammatory activity, as confirmed by the COX-2 inhibitory assay. Notably, this is the first report of the COX-2 inhibitory effects of sanleng acid, stachysterone D, dihydroactinidiolide, N-cis-feruloyl-3-methoxytyramine, 9,12,13-trihydroxy-10-octadecenoic acid, azelaic acid, and dehydroecdysone.